[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fYFVKM_8p_SKCRFwmWmACgDSfQHMoWdAzjtUJr9AbUfA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":33,"phaseBuckets":44,"rows":51},"University of Bergen",[4],140,false,19,2,178952,122,[13,16,18,21,23,26,29,31],{"name":14,"count":15},"Dementia",6,{"name":17,"count":15},"Healthy",{"name":19,"count":20},"Pain",5,{"name":22,"count":20},"Obesity",{"name":24,"count":25},"Depression",4,{"name":27,"count":28},"Anxiety",3,{"name":30,"count":28},"Periodontitis",{"name":32,"count":28},"Sleep",[34,39],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT04706390","Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination","2024-12-12","covid-19 vaccine",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT01866540","Immune Response To Intranasal Influenza Vaccination","2025-12-31","FLUENZ",[45,46,47,48,49,50],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[52,77,100,142,169,187,216,244,262,280,298,316,334,352,377,403,421,439,457,483,509,535,553,571,598,616,641,667,693,717],{"intervention":43,"totalTrials":53,"cells":54},1,{"EARLY_PHASE1":55,"PHASE1":58,"PHASE2":60,"PHASE3":62,"PHASE4":64,"NA":66},{"trials":56,"activeCount":57},[],0,{"trials":59,"activeCount":57},[],{"trials":61,"activeCount":57},[],{"trials":63,"activeCount":57},[],{"trials":65,"activeCount":57},[],{"trials":67,"activeCount":53,"soonestReadout":42},[68],{"nctId":40,"briefTitle":41,"status":69,"phases":70,"primaryCompletion":42,"completion":71,"start":72,"enrollment":73,"conditions":74,"interventions":76},"ACTIVE_NOT_RECRUITING",[50],"2030-12-31","2012-10-01",300,[75],"Tonsillitis, Hypertrophy",[43],{"intervention":38,"totalTrials":53,"cells":78},{"EARLY_PHASE1":79,"PHASE1":81,"PHASE2":83,"PHASE3":85,"PHASE4":87,"NA":89},{"trials":80,"activeCount":57},[],{"trials":82,"activeCount":57},[],{"trials":84,"activeCount":57},[],{"trials":86,"activeCount":57},[],{"trials":88,"activeCount":57},[],{"trials":90,"activeCount":53,"soonestReadout":37},[91],{"nctId":35,"briefTitle":36,"status":92,"phases":93,"primaryCompletion":37,"completion":94,"start":95,"enrollment":96,"conditions":97,"interventions":99},"RECRUITING",[],"2030-12-12","2021-01-12",2500,[98],"Covid19",[38],{"intervention":101,"totalTrials":9,"cells":102},"Paracetamol",{"EARLY_PHASE1":103,"PHASE1":105,"PHASE2":107,"PHASE3":109,"PHASE4":126,"NA":140},{"trials":104,"activeCount":57},[],{"trials":106,"activeCount":57},[],{"trials":108,"activeCount":57},[],{"trials":110,"activeCount":57},[111],{"nctId":112,"briefTitle":113,"status":114,"phases":115,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":120,"interventions":122},"NCT01021696","Pain in Patients With Dementia and Behavioural Disturbances","COMPLETED",[47,48],"2010-07","2010-10","2009-11",352,[14,19,121],"Agitation",[101,123,124,125],"Morphine","Buprenorphine plaster","Pregabalin",{"trials":127,"activeCount":57},[128],{"nctId":129,"briefTitle":130,"status":114,"phases":131,"primaryCompletion":132,"completion":132,"start":133,"enrollment":134,"conditions":135,"interventions":136},"NCT02267057","Efficacy of Pain Treatment on Depression in Patients With Dementia",[49],"2016-12-21","2014-08",163,[24,19,14],[101,137,138,139],"Buprenorphine","Paracetamol placebo","Buprenorphine placebo",{"trials":141,"activeCount":57},[],{"intervention":143,"totalTrials":53,"cells":144},"Inactivated influenza vaccine",{"EARLY_PHASE1":145,"PHASE1":147,"PHASE2":149,"PHASE3":151,"PHASE4":153,"NA":167},{"trials":146,"activeCount":57},[],{"trials":148,"activeCount":57},[],{"trials":150,"activeCount":57},[],{"trials":152,"activeCount":57},[],{"trials":154,"activeCount":57},[155],{"nctId":156,"briefTitle":157,"status":158,"phases":159,"primaryCompletion":160,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":165},"NCT04998344","An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh","UNKNOWN",[49],"2024-12-31","2021-04-07",3800,[164],"Influenza Viral Infections",[143,166],"Inactivated polio vaccine",{"trials":168,"activeCount":57},[],{"intervention":166,"totalTrials":53,"cells":170},{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":177,"PHASE4":179,"NA":185},{"trials":172,"activeCount":57},[],{"trials":174,"activeCount":57},[],{"trials":176,"activeCount":57},[],{"trials":178,"activeCount":57},[],{"trials":180,"activeCount":57},[181],{"nctId":156,"briefTitle":157,"status":158,"phases":182,"primaryCompletion":160,"completion":160,"start":161,"enrollment":162,"conditions":183,"interventions":184},[49],[164],[143,166],{"trials":186,"activeCount":57},[],{"intervention":188,"totalTrials":53,"cells":189},"Cotrimoxazole",{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":214},{"trials":191,"activeCount":57},[],{"trials":193,"activeCount":57},[],{"trials":195,"activeCount":57},[],{"trials":197,"activeCount":57},[],{"trials":199,"activeCount":57},[200],{"nctId":201,"briefTitle":202,"status":114,"phases":203,"primaryCompletion":204,"completion":204,"start":205,"enrollment":206,"conditions":207,"interventions":213},"NCT03087890","Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria",[49],"2019-07-25","2017-03-30",537,[208,209,210,211,212],"HIV-1-infection","Pneumocystis Pneumonia","Opportunistic Infections","Preventive Therapy","Antibiotic Side Effect",[188],{"trials":215,"activeCount":57},[],{"intervention":217,"totalTrials":53,"cells":218},"Olanzapine",{"EARLY_PHASE1":219,"PHASE1":221,"PHASE2":223,"PHASE3":225,"PHASE4":227,"NA":242},{"trials":220,"activeCount":57},[],{"trials":222,"activeCount":57},[],{"trials":224,"activeCount":57},[],{"trials":226,"activeCount":57},[],{"trials":228,"activeCount":57},[229],{"nctId":230,"briefTitle":231,"status":114,"phases":232,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":236,"interventions":238},"NCT00932529","Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting",[49],"2010-01","2003-02",226,[237],"Psychotic Disorders",[217,239,240,241],"Quetiapine","Risperidone","Ziprasidone",{"trials":243,"activeCount":57},[],{"intervention":239,"totalTrials":53,"cells":245},{"EARLY_PHASE1":246,"PHASE1":248,"PHASE2":250,"PHASE3":252,"PHASE4":254,"NA":260},{"trials":247,"activeCount":57},[],{"trials":249,"activeCount":57},[],{"trials":251,"activeCount":57},[],{"trials":253,"activeCount":57},[],{"trials":255,"activeCount":57},[256],{"nctId":230,"briefTitle":231,"status":114,"phases":257,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":258,"interventions":259},[49],[237],[217,239,240,241],{"trials":261,"activeCount":57},[],{"intervention":240,"totalTrials":53,"cells":263},{"EARLY_PHASE1":264,"PHASE1":266,"PHASE2":268,"PHASE3":270,"PHASE4":272,"NA":278},{"trials":265,"activeCount":57},[],{"trials":267,"activeCount":57},[],{"trials":269,"activeCount":57},[],{"trials":271,"activeCount":57},[],{"trials":273,"activeCount":57},[274],{"nctId":230,"briefTitle":231,"status":114,"phases":275,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":276,"interventions":277},[49],[237],[217,239,240,241],{"trials":279,"activeCount":57},[],{"intervention":241,"totalTrials":53,"cells":281},{"EARLY_PHASE1":282,"PHASE1":284,"PHASE2":286,"PHASE3":288,"PHASE4":290,"NA":296},{"trials":283,"activeCount":57},[],{"trials":285,"activeCount":57},[],{"trials":287,"activeCount":57},[],{"trials":289,"activeCount":57},[],{"trials":291,"activeCount":57},[292],{"nctId":230,"briefTitle":231,"status":114,"phases":293,"primaryCompletion":233,"completion":233,"start":234,"enrollment":235,"conditions":294,"interventions":295},[49],[237],[217,239,240,241],{"trials":297,"activeCount":57},[],{"intervention":137,"totalTrials":53,"cells":299},{"EARLY_PHASE1":300,"PHASE1":302,"PHASE2":304,"PHASE3":306,"PHASE4":308,"NA":314},{"trials":301,"activeCount":57},[],{"trials":303,"activeCount":57},[],{"trials":305,"activeCount":57},[],{"trials":307,"activeCount":57},[],{"trials":309,"activeCount":57},[310],{"nctId":129,"briefTitle":130,"status":114,"phases":311,"primaryCompletion":132,"completion":132,"start":133,"enrollment":134,"conditions":312,"interventions":313},[49],[24,19,14],[101,137,138,139],{"trials":315,"activeCount":57},[],{"intervention":138,"totalTrials":53,"cells":317},{"EARLY_PHASE1":318,"PHASE1":320,"PHASE2":322,"PHASE3":324,"PHASE4":326,"NA":332},{"trials":319,"activeCount":57},[],{"trials":321,"activeCount":57},[],{"trials":323,"activeCount":57},[],{"trials":325,"activeCount":57},[],{"trials":327,"activeCount":57},[328],{"nctId":129,"briefTitle":130,"status":114,"phases":329,"primaryCompletion":132,"completion":132,"start":133,"enrollment":134,"conditions":330,"interventions":331},[49],[24,19,14],[101,137,138,139],{"trials":333,"activeCount":57},[],{"intervention":139,"totalTrials":53,"cells":335},{"EARLY_PHASE1":336,"PHASE1":338,"PHASE2":340,"PHASE3":342,"PHASE4":344,"NA":350},{"trials":337,"activeCount":57},[],{"trials":339,"activeCount":57},[],{"trials":341,"activeCount":57},[],{"trials":343,"activeCount":57},[],{"trials":345,"activeCount":57},[346],{"nctId":129,"briefTitle":130,"status":114,"phases":347,"primaryCompletion":132,"completion":132,"start":133,"enrollment":134,"conditions":348,"interventions":349},[49],[24,19,14],[101,137,138,139],{"trials":351,"activeCount":57},[],{"intervention":353,"totalTrials":53,"cells":354},"Zopiclone",{"EARLY_PHASE1":355,"PHASE1":357,"PHASE2":359,"PHASE3":361,"PHASE4":363,"NA":375},{"trials":356,"activeCount":57},[],{"trials":358,"activeCount":57},[],{"trials":360,"activeCount":57},[],{"trials":362,"activeCount":57},[],{"trials":364,"activeCount":57},[365],{"nctId":366,"briefTitle":367,"status":114,"phases":368,"primaryCompletion":369,"completion":370,"start":371,"conditions":372,"interventions":374},"NCT00295386","Cognitive-Behavioural and Hypnotic Treatment of Chronic Primary Insomnia Among the Elderly",[49],"2006-01","2007-12","2004-01",[373],"Insomnia",[353],{"trials":376,"activeCount":57},[],{"intervention":378,"totalTrials":53,"cells":379},"Advanced medicinal Therapy",{"EARLY_PHASE1":380,"PHASE1":382,"PHASE2":384,"PHASE3":386,"PHASE4":399,"NA":401},{"trials":381,"activeCount":57},[],{"trials":383,"activeCount":57},[],{"trials":385,"activeCount":57},[],{"trials":387,"activeCount":57},[388],{"nctId":389,"briefTitle":390,"status":114,"phases":391,"primaryCompletion":392,"completion":393,"start":394,"enrollment":395,"conditions":396,"interventions":398},"NCT04297813","Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting",[48],"2023-07-31","2024-07-31","2020-03-12",48,[397],"Alveolar Bone Atrophy",[378],{"trials":400,"activeCount":57},[],{"trials":402,"activeCount":57},[],{"intervention":123,"totalTrials":53,"cells":404},{"EARLY_PHASE1":405,"PHASE1":407,"PHASE2":409,"PHASE3":411,"PHASE4":417,"NA":419},{"trials":406,"activeCount":57},[],{"trials":408,"activeCount":57},[],{"trials":410,"activeCount":57},[],{"trials":412,"activeCount":57},[413],{"nctId":112,"briefTitle":113,"status":114,"phases":414,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":415,"interventions":416},[47,48],[14,19,121],[101,123,124,125],{"trials":418,"activeCount":57},[],{"trials":420,"activeCount":57},[],{"intervention":124,"totalTrials":53,"cells":422},{"EARLY_PHASE1":423,"PHASE1":425,"PHASE2":427,"PHASE3":429,"PHASE4":435,"NA":437},{"trials":424,"activeCount":57},[],{"trials":426,"activeCount":57},[],{"trials":428,"activeCount":57},[],{"trials":430,"activeCount":57},[431],{"nctId":112,"briefTitle":113,"status":114,"phases":432,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":433,"interventions":434},[47,48],[14,19,121],[101,123,124,125],{"trials":436,"activeCount":57},[],{"trials":438,"activeCount":57},[],{"intervention":125,"totalTrials":53,"cells":440},{"EARLY_PHASE1":441,"PHASE1":443,"PHASE2":445,"PHASE3":447,"PHASE4":453,"NA":455},{"trials":442,"activeCount":57},[],{"trials":444,"activeCount":57},[],{"trials":446,"activeCount":57},[],{"trials":448,"activeCount":57},[449],{"nctId":112,"briefTitle":113,"status":114,"phases":450,"primaryCompletion":116,"completion":117,"start":118,"enrollment":119,"conditions":451,"interventions":452},[47,48],[14,19,121],[101,123,124,125],{"trials":454,"activeCount":57},[],{"trials":456,"activeCount":57},[],{"intervention":458,"totalTrials":53,"cells":459},"Combined use of azacitidine, valproic acid, hydroxurea and eventually donor leukocyte infusions.",{"EARLY_PHASE1":460,"PHASE1":462,"PHASE2":464,"PHASE3":477,"PHASE4":479,"NA":481},{"trials":461,"activeCount":57},[],{"trials":463,"activeCount":57},[],{"trials":465,"activeCount":57},[466],{"nctId":467,"briefTitle":468,"status":158,"phases":469,"primaryCompletion":470,"completion":471,"start":472,"enrollment":473,"conditions":474,"interventions":476},"NCT01369368","Treatment of Acute Leukemia Relapse After Allotransplantation",[46,47],"2017-10","2020-10","2013-08",20,[475],"Acute Myeloid Leukemia",[458],{"trials":478,"activeCount":57},[],{"trials":480,"activeCount":57},[],{"trials":482,"activeCount":57},[],{"intervention":484,"totalTrials":53,"cells":485},"Cytarabine, all-trans retinoic acid, valproic acid",{"EARLY_PHASE1":486,"PHASE1":488,"PHASE2":490,"PHASE3":503,"PHASE4":505,"NA":507},{"trials":487,"activeCount":57},[],{"trials":489,"activeCount":57},[],{"trials":491,"activeCount":57},[492],{"nctId":493,"briefTitle":494,"status":114,"phases":495,"primaryCompletion":496,"completion":497,"start":498,"enrollment":499,"conditions":500,"interventions":502},"NCT00995332","Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine",[46,47],"2013-02","2013-06","2009-09",36,[501],"Acute Myelogenous Leukemia",[484],{"trials":504,"activeCount":57},[],{"trials":506,"activeCount":57},[],{"trials":508,"activeCount":57},[],{"intervention":510,"totalTrials":53,"cells":511},"all-trans retinoic acid",{"EARLY_PHASE1":512,"PHASE1":514,"PHASE2":516,"PHASE3":529,"PHASE4":531,"NA":533},{"trials":513,"activeCount":57},[],{"trials":515,"activeCount":57},[],{"trials":517,"activeCount":57},[518],{"nctId":519,"briefTitle":520,"status":114,"phases":521,"primaryCompletion":522,"completion":118,"start":523,"enrollment":524,"conditions":525,"interventions":526},"NCT00175812","Differentiation Induction in Acute Myelogenous Leukemia",[46,47],"2008-05","2004-11",24,[501],[510,527,528],"Valproic acid","Theophyllin",{"trials":530,"activeCount":57},[],{"trials":532,"activeCount":57},[],{"trials":534,"activeCount":57},[],{"intervention":527,"totalTrials":53,"cells":536},{"EARLY_PHASE1":537,"PHASE1":539,"PHASE2":541,"PHASE3":547,"PHASE4":549,"NA":551},{"trials":538,"activeCount":57},[],{"trials":540,"activeCount":57},[],{"trials":542,"activeCount":57},[543],{"nctId":519,"briefTitle":520,"status":114,"phases":544,"primaryCompletion":522,"completion":118,"start":523,"enrollment":524,"conditions":545,"interventions":546},[46,47],[501],[510,527,528],{"trials":548,"activeCount":57},[],{"trials":550,"activeCount":57},[],{"trials":552,"activeCount":57},[],{"intervention":528,"totalTrials":53,"cells":554},{"EARLY_PHASE1":555,"PHASE1":557,"PHASE2":559,"PHASE3":565,"PHASE4":567,"NA":569},{"trials":556,"activeCount":57},[],{"trials":558,"activeCount":57},[],{"trials":560,"activeCount":57},[561],{"nctId":519,"briefTitle":520,"status":114,"phases":562,"primaryCompletion":522,"completion":118,"start":523,"enrollment":524,"conditions":563,"interventions":564},[46,47],[501],[510,527,528],{"trials":566,"activeCount":57},[],{"trials":568,"activeCount":57},[],{"trials":570,"activeCount":57},[],{"intervention":572,"totalTrials":53,"cells":573},"Rituximab",{"EARLY_PHASE1":574,"PHASE1":576,"PHASE2":578,"PHASE3":592,"PHASE4":594,"NA":596},{"trials":575,"activeCount":57},[],{"trials":577,"activeCount":57},[],{"trials":579,"activeCount":57},[580],{"nctId":581,"briefTitle":582,"status":114,"phases":583,"primaryCompletion":584,"completion":585,"start":586,"enrollment":587,"conditions":588,"interventions":590},"NCT00373594","Therapy for Chronic Cold Agglutinin Disease",[47],"2010-04","2010-05","2005-06",30,[589],"Cold Agglutinin Disease",[572,591],"Fludarabine",{"trials":593,"activeCount":57},[],{"trials":595,"activeCount":57},[],{"trials":597,"activeCount":57},[],{"intervention":591,"totalTrials":53,"cells":599},{"EARLY_PHASE1":600,"PHASE1":602,"PHASE2":604,"PHASE3":610,"PHASE4":612,"NA":614},{"trials":601,"activeCount":57},[],{"trials":603,"activeCount":57},[],{"trials":605,"activeCount":57},[606],{"nctId":581,"briefTitle":582,"status":114,"phases":607,"primaryCompletion":584,"completion":585,"start":586,"enrollment":587,"conditions":608,"interventions":609},[47],[589],[572,591],{"trials":611,"activeCount":57},[],{"trials":613,"activeCount":57},[],{"trials":615,"activeCount":57},[],{"intervention":617,"totalTrials":53,"cells":618},"TW11681 or TW10722",{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":633,"PHASE3":635,"PHASE4":637,"NA":639},{"trials":620,"activeCount":57},[],{"trials":622,"activeCount":57},[623],{"nctId":624,"briefTitle":625,"status":158,"phases":626,"primaryCompletion":627,"completion":628,"start":629,"enrollment":587,"conditions":630,"interventions":632},"NCT02870751","Human Challenge Model With ST-only Enterotoxigenic Escherichia Coli",[46],"2018-12","2019-09","2016-05",[631],"Diarrhea, Infantile",[617],{"trials":634,"activeCount":57},[],{"trials":636,"activeCount":57},[],{"trials":638,"activeCount":57},[],{"trials":640,"activeCount":57},[],{"intervention":642,"totalTrials":53,"cells":643},"BCP with autologous mesenchymal stem cells (MSC).",{"EARLY_PHASE1":644,"PHASE1":646,"PHASE2":659,"PHASE3":661,"PHASE4":663,"NA":665},{"trials":645,"activeCount":57},[],{"trials":647,"activeCount":57},[648],{"nctId":649,"briefTitle":650,"status":114,"phases":651,"primaryCompletion":652,"completion":653,"start":654,"enrollment":655,"conditions":656,"interventions":658},"NCT02751125","Reconstruction of Jaw Bone Using Mesenchymal Stem Cells",[46],"2019-03-01","2020-03-01","2014-06",13,[657],"Bone Atrophy",[642],{"trials":660,"activeCount":57},[],{"trials":662,"activeCount":57},[],{"trials":664,"activeCount":57},[],{"trials":666,"activeCount":57},[],{"intervention":668,"totalTrials":53,"cells":669},"parathyroid hormon 1-84",{"EARLY_PHASE1":670,"PHASE1":683,"PHASE2":685,"PHASE3":687,"PHASE4":689,"NA":691},{"trials":671,"activeCount":57},[672],{"nctId":673,"briefTitle":674,"status":158,"phases":675,"primaryCompletion":676,"completion":677,"start":678,"enrollment":587,"conditions":679,"interventions":682},"NCT02986607","Corticosteroid Rhythms in Hypoparathyroid Patients",[45],"2018-01","2018-06","2016-03",[680,681],"Hypoparathyroidism","Hyperparathyroidism",[668],{"trials":684,"activeCount":57},[],{"trials":686,"activeCount":57},[],{"trials":688,"activeCount":57},[],{"trials":690,"activeCount":57},[],{"trials":692,"activeCount":57},[],{"intervention":694,"totalTrials":53,"cells":695},"Adjuvanted influenza H1N1split virion vaccine",{"EARLY_PHASE1":696,"PHASE1":698,"PHASE2":700,"PHASE3":702,"PHASE4":704,"NA":706},{"trials":697,"activeCount":57},[],{"trials":699,"activeCount":57},[],{"trials":701,"activeCount":57},[],{"trials":703,"activeCount":57},[],{"trials":705,"activeCount":57},[],{"trials":707,"activeCount":57},[708],{"nctId":709,"briefTitle":710,"status":114,"phases":711,"primaryCompletion":233,"completion":712,"start":713,"enrollment":714,"conditions":715,"interventions":716},"NCT01003288","Studies of Pandemic Influenza (H1N1) 2009 Vaccine in Bergen",[50],"2014-12","2009-10",255,[17],[694],{"intervention":718,"totalTrials":53,"cells":719},"spot urine samples",{"EARLY_PHASE1":720,"PHASE1":722,"PHASE2":724,"PHASE3":726,"PHASE4":728,"NA":730},{"trials":721,"activeCount":57},[],{"trials":723,"activeCount":57},[],{"trials":725,"activeCount":57},[],{"trials":727,"activeCount":57},[],{"trials":729,"activeCount":57},[],{"trials":731,"activeCount":57},[732],{"nctId":733,"briefTitle":734,"status":114,"phases":735,"primaryCompletion":736,"completion":737,"start":738,"enrollment":739,"conditions":740,"interventions":742},"NCT05934006","Comparison of I-FFQ and Two Reference Methods",[],"2022-01-01","2022-06-15","2021-08-10",72,[741],"Iodine Deficiency",[718]]